What are you looking for?

Library
Presentation
Full Title

Alterations of the Sputum Proteome and Transcriptome and Serum Lipidome from Smokers and Early-Stage COPD Subjects


Authored by  T Schneider

Presented at 5th International Conference on Analytical Proteomics (V ICAP 2017)    
V ICAP 2017_Schneider_Alterations of the sputum proteome and transcriptome_Screenshot
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced-risk products ("RRPs") is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.